Loss of COP9 signalosome genes at 2q37 is associated with IMiD resistance in multiple myeloma. (2022)

First Author: Gooding S
Attributed to:  Biology and Treatment of Human Myeloid Cancers funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2022015909

PubMed Identifier: 35853156

Publication URI: http://europepmc.org/abstract/MED/35853156

Type: Journal Article/Review

Volume: 140

Parent Publication: Blood

Issue: 16

ISSN: 0006-4971